Understanding how a specific histone mutation affects brain tumor development in children
Investigating the role of dysfunctional histone H3.3 in driving early neuronal development and pediatric high-grade gliomas
This study is looking at how a specific change in a gene related to brain development might lead to brain tumors in kids, with the hope that understanding this could help find better treatments for these tough-to-treat tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11097333 on NIH RePORTER |
What this research studies
This research investigates the role of a specific mutation in histone H3.3 and its impact on early brain development and the formation of high-grade gliomas in children. By using a genetically engineered mouse model, researchers aim to uncover the molecular mechanisms that drive these tumors, which are currently difficult to treat. The study focuses on how this mutation interacts with other genetic factors to promote tumor growth, potentially leading to new therapeutic targets. Patients may benefit from insights gained that could inform future treatment strategies for pediatric brain tumors.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are children diagnosed with high-grade gliomas, particularly those with the H3.3-G34R mutation.
Not a fit: Patients with brain tumors that do not involve the H3.3-G34R mutation or those with other types of pediatric brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for pediatric high-grade gliomas, improving outcomes for affected children.
How similar studies have performed: Previous research has shown promising results in understanding the genetic underpinnings of pediatric brain tumors, suggesting that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Hu, Jian — University of Tx Md Anderson Can Ctr
- Study coordinator: Hu, Jian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.